Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NYSEFinancialsBanks - RegionalSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.40 → 4.40 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 4 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for HTB yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Quarterly dividend increases continue | Management increased the quarterly dividend, signaling financial strength. | Intact | No dividend increase or dividend cut in the next 4 quarters | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
HTB is a regional bank investment with a measured growth and capital-return case, rather than a clear turnaround. The long-term thesis is intact, but execution on loan growth and the Blue Ridge Bankshares acquisition remains part of the evidence to watch.
Valuation is roughly aligned with peers, and the expectations gap is modestly negative, meaning expectations appear somewhat ahead of the evidence. The priced-in assessment is tagged justified, with low fragility, so the snapshot does not point to unusually concentrated expectations.
Near-term results have shown improvement: HTB recently reported an earnings beat, and company momentum rose from 31.4 to 52.9. Loan growth reached 8.5% annualized in 2026-Q2, or 14.6% excluding portfolios being reduced, while the recent miss risk is assessed as low but not absent. The acquisition has no established completion or synergy milestones in the supplied evidence.
Over the next few quarters, the thesis hinges on continued loan growth and whether management can show tangible progress on the Blue Ridge Bankshares acquisition. A guidance cut would be a meaningful negative; rate cuts could also weigh on the sector, while continued strong results from financial-sector peers would support sector momentum.
For the 1-to-3-year view, HTB’s thesis remains intact, with improving momentum and concrete repurchases balanced by execution needs and sensitivity to rates. The evidence is mixed on the acquisition, so its progress remains an important test. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company has a strong track record of earnings beats and completed a 5% stock buyback. |
| Improving |
| Fewer than 3 earnings beats in the next 4 quarters |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
EPS at or above $0.99 in FY26 | A primary condition in HomeTrust Bancshares, Inc.'s published investment case. The stated target is >=0.99 USD per share. | Intact | EPS falls below $0.99 in FY26 | Diluted EPS: $0.94 per share FY2026-Q4; GAAP. Published target: >=0.99 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 20260.94 USD/share · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.72 → $4.40 · observed estimates
$0.22B → $0.33B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.72 | $218,772,500 | 5 / 2 |
| 2026-07-25 | $3.72 | $220,311,250 | 4 / 2 |
| 2026-07-26 | $3.72 | $218,772,500 | 5 / 2 |
| 2026-07-27 | $3.72 | $220,311,250 | 4 / 2 |
| 2026-07-28 | $3.72 | $218,772,500 | 5 / 2 |
| 2026-07-29 | $3.72 | $220,311,250 | 4 / 2 |
| 2026-07-30 | $3.89 | $226,049,670 | 5 / 3 |
| 2026-07-31 | $3.89 | $226,049,670 | 5 / 3 |
| 2026-08-01 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-02 | $3.89 | $226,049,670 | 5 / 3 |
| 2026-08-03 | $3.89 | $226,049,670 | 5 / 3 |
| 2026-08-04 | $3.89 | $226,049,670 | 5 / 3 |
| 2026-08-05 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-06 | $3.89 | $226,049,670 | 5 / 3 |
| 2026-08-07 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-08 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-09 | $3.89 | $226,049,670 | 5 / 3 |
| 2026-08-10 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-12 | $3.83 | $226,049,670 | 5 / 3 |
| 2026-08-13 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-14 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-15 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-16 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-17 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-18 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-19 | $3.89 | $225,687,250 | 4 / 2 |
| 2026-08-20 | $4.35 | $312,012,250 | 3 / 2 |
| 2026-08-21 | $4.35 | $312,012,250 | 3 / 2 |
| 2026-08-22 | $4.50 | $340,366,750 | 3 / 2 |
| 2026-08-23 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-08-24 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-08-25 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-08-26 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-08-27 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-08-28 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-08-29 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-08-30 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-08-31 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-01 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-02 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-03 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-04 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-05 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-06 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-07 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-08 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-09 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-10 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-11 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-12 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-13 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-14 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-15 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-16 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-17 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-18 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-19 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-20 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-21 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-22 | $4.50 | $340,366,750 | 4 / 2 |
| 2026-09-23 | $4.50 | $340,401,500 | 4 / 2 |
| 2026-09-24 | $4.50 | $340,401,500 | 4 / 2 |
| 2026-09-25 | $4.50 | $340,401,500 | 4 / 2 |
| 2026-09-26 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-09-27 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-09-28 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-09-29 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-09-30 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-10-01 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-10-02 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-10-03 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-10-04 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-10-05 | $4.50 | $340,401,500 | 4 / 3 |
| 2026-10-06 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-07 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-08 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-09 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-10 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-11 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-12 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-13 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-14 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-15 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-16 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-17 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-18 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-19 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-20 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-21 | $4.40 | $337,901,500 | 4 / 3 |
| 2026-10-22 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-10-23 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-10-24 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-10-25 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-10-26 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-10-27 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-10-28 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-10-29 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-10-30 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-10-31 | $4.40 | $334,155,500 | 4 / 3 |
| 2026-11-01 | $4.40 | $333,380,500 | 4 / 3 |
| 2026-11-02 | $4.40 | $333,380,500 | 4 / 3 |
| 2026-11-03 | $4.40 | $333,380,500 | 4 / 3 |
| 2026-11-04 | $4.40 | $333,380,500 | 4 / 3 |
| 2026-11-05 | $4.40 | $333,380,500 | 4 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.